Cargando…

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation

The endocannabinoid system (ECS) is involved in many physiological processes and has been suggested to play a critical role in the immune response and the central nervous system (CNS). Therefore, ECS modulation has potential therapeutic effects on immune dysfunctional disorders, such as sepsis and C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Juan, Burkovskiy, Ian, Yang, Hyewon, Sardinha, Joel, Lehmann, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992728/ https://www.ncbi.nlm.nih.gov/pubmed/27597829 http://dx.doi.org/10.3389/fphar.2016.00264

Ejemplares similares

The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015)

Functional characterization of the novel cannabinoid receptor GPR55 and its modulation by CB(1 )and CB(2 )receptors
por: Balenga, Nariman, et al.
Publicado: (2008)

Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
por: Guerrero-Alba, Raquel, et al.
Publicado: (2019)

Characterization of different G protein coupling properties of CB(1 )and CB(2 )cannabinoid receptors and GPR55 receptor using BRET
por: Gyombolai, Pál, et al.
Publicado: (2009)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors
por: Martínez-Aguilar, Lizbeth Magnolia, et al.
Publicado: (2023)

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
por: El-Atawneh, Shayma, et al.
Publicado: (2022)

Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint
por: Zamith Cunha, Rodrigo, et al.
Publicado: (2023)

GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats
por: Zúñiga-Romero, Ángel, et al.
Publicado: (2022)

Identification of G protein-coupled receptor 55 (GPR55) as a target of curcumin
por: Harada, Naoki, et al.
Publicado: (2022)

O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
por: Wróbel, Andrzej, et al.
Publicado: (2020)

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB(2) Receptors
por: Franco, Rafael, et al.
Publicado: (2022)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
por: Soderstrom, Ken, et al.
Publicado: (2017)

Enhanced self-administration of the CB(1) receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
por: Amchova, Petra, et al.
Publicado: (2014)

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021)

Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Expression and Functions of the CB(2) Receptor in Human Leukocytes
por: Simard, Mélissa, et al.
Publicado: (2022)

CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation
por: Van Waes, Vincent, et al.
Publicado: (2012)

Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats
por: Patricio, Felipe, et al.
Publicado: (2022)

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
por: Hashiesh, Hebaallah Mamdouh, et al.
Publicado: (2021)

Central CB(2) receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential
por: Concannon, Ruth M., et al.
Publicado: (2016)

The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in App(NL-G-F) Knock-In Mice
por: Medina-Vera, Dina, et al.
Publicado: (2023)

Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1
por: Smith, Nicola J.
Publicado: (2015)

Potential Metabolic and Behavioural Roles of the Putative Endo- cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
por: Ramírez-Orozco, Ricardo E., et al.
Publicado: (2019)

Ginseng Gintonin Contains Ligands for GPR40 and GPR55
por: Cho, Yeon-Jin, et al.
Publicado: (2020)

Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
por: Leyva-Illades, Dinorah, et al.
Publicado: (2013)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
por: Jha, Niraj Kumar, et al.
Publicado: (2021)

Role of GPR55 during Axon Growth and Target Innervation
por: Cherif, Hosni, et al.
Publicado: (2015)

Peptide-guided targeting of GPR55 for anti-cancer therapy
por: Mangini, Maria, et al.
Publicado: (2016)

Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning
por: Mosca, Maria Giovanna, et al.
Publicado: (2021)

Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
por: Kaushik, Aman Chandra, et al.
Publicado: (2021)

GPR55: signaling pathways and functions
por: Balenga, Nariman, et al.
Publicado: (2009)

Dysregulation of lncRNAs in Rheumatoid Arthritis: Biomarkers, Pathogenesis and Potential Therapeutic Targets
por: Miao, Chenggui, et al.
Publicado: (2021)

Cannabinoid 2 receptor antagonism reverses central nervous system injury-induced immune deficiency syndrome
por: Burkovskiy, IB, et al.
Publicado: (2015)

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB(2) Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis
por: Sisay, Sofia, et al.
Publicado: (2013)

Expression of the putative cannabinoid receptor GPR55 is increased in endometrial carcinoma
por: Ayakannu, Thangesweran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h3tmobkisfm0e1jir1bg9ppi8h